Eisai Refiles Mecobalamin For ALS In Japan After Seven Years

 
• By Lisa Takagi
  
If approved, mecobalamin can expand the treatment option for early ALS patients.
mecobalamin would expand ALS options in Japan if approved • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia